Kazuhiro Takehara
Papers
1
Total Citations
5
H-Index
1
About
Kazuhiro Takehara is a leading figure in gynecologic oncology, with a primary research focus on refining surgical treatments for uterine cervical cancer. His most impactful work centers on de-escalating surgical invasiveness without compromising oncologic safety. He is best known for spearheading the Japan Clinical Oncology Group study, JCOG1101, a landmark confirmatory trial that evaluated modified radical hysterectomy for patients with FIGO stage IB1 cervical cancer with tumors 2 cm or less. This pivotal study, published in 2023, directly challenged the standard of highly invasive Piver class III hysterectomy, providing robust evidence for a less radical, nerve-sparing approach. While his most-cited paper has garnered 5 citations, its significance lies in its potential to reshape clinical guidelines and improve patient quality of life by reducing surgical morbidity. Dr. Takehara’s work is instrumental in the global movement toward personalized, minimally invasive cancer care, establishing him as a key contributor to evidence-based surgical de-escalation in early-stage cervical cancer.
Research Focus
Key Achievements
Top Papers
- 1